They are not the same thing at all. Or are they? The FDA may think so, and it can impact your clinical data and evaluation plans. Listen in as Greg Kunst and I explain the differences…..and the similarities.

November 20, 2019
By Michelle Lott
They are not the same thing at all. Or are they? The FDA may think so, and it can impact your clinical data and evaluation plans. Listen in as Greg Kunst and I explain the differences…..and the similarities.
The More You Know 2: How to Identify a Fraudulent N95 Mask
What do you say to your elderly neighbor when they show you the fraudulent N95 mask they bought online? Repeat
Learn MoreChoosing the Right FDA Pathway for Your Product, Component or Accessory
Choosing the right FDA pathway for your product is not easy and can be fraught with regulatory landmines. But by
Learn MoreMichelle Lott and State of the Art – Live in London!
At the 10x MedDev Conference in London, I spoke in detail about the regulatory definition of state of the art,
Learn More